According to the present study , CoQ@ , when given at a dose of @ mg/d for @ weeks to a group of neuropathic diabetic patients , did not improve the neuropathy signs compared to placebo , although it had some beneficial effects on TAC and hsCRP and probably a protective effect on insulin resistance .